Drug Target Analysis in the Human Central Nervous System
Closed Solicitation Posted
- Solicitation number
- FDASBRFP75F40124Q00344
- Agency
-
National Center for Toxicological Research
Food and Drug Administration, Department of Health and Human Services
- Responses due
- Set-aside
- Total Small Business
Opportunity facts
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The U.S. Food and Drug Administration's (FDA) National Center for Toxicological Research (NCTR) is seeking protein binding and functional assay services to identify and verify drug targets in the human central nervous system that are potentially associated with adverse neuropsychiatric effects. The required services must analyze over 14 protein targets/receptors and provide results in either agonist or antagonist or both formats, with delivery within 30 days after receipt of the test article. Responses are due by 1:00 PM Central Time on July 7, 2024 and should be submitted by email.
This procurement is set aside for small businesses. There is no information provided on potential incumbents or current contractors. The contract value is not specified, and the place of performance is not stated. This is a one-time analysis with no option periods.
Notice text
Title: Drug Target Analysis in the Human Central Nervous System
Questions are due1PM EST 06/26/2024
Proposals are due 1PM EST 07/07/204
Files
| File | Type | Posted |
|---|---|---|
| SB- RFQ-75F40124Q00344.docx | DOCX document |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Tau radiotracers for Baltimore Longitudinal Study of Aging | National Institute on Drug Abuse | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity